These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 18426831

  • 1. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S, Kajaia N, Dittrich R, Duezenli H, W Beckmann M, Mueller A.
    Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
    [Abstract] [Full Text] [Related]

  • 2. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [Abstract] [Full Text] [Related]

  • 3. Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome.
    Kajaia N, Binder H, Dittrich R, Oppelt PG, Flor B, Cupisti S, Beckmann MW, Mueller A.
    Eur J Endocrinol; 2007 Oct; 157(4):499-507. PubMed ID: 17893265
    [Abstract] [Full Text] [Related]

  • 4. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U, Ezeh C, Pisarska MD, Azziz R.
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [Abstract] [Full Text] [Related]

  • 5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 07; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 7. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI.
    J Clin Endocrinol Metab; 1999 Nov 07; 84(11):4006-11. PubMed ID: 10566641
    [Abstract] [Full Text] [Related]

  • 8. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 07; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 9. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct 07; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 10. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, Trakakis E.
    J Am Acad Dermatol; 2013 Dec 07; 69(6):922-30. PubMed ID: 24120563
    [Abstract] [Full Text] [Related]

  • 11. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr 07; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
    Zhao H, Song X, Zhang L, Xu Y, Wang X.
    Med Sci Monit; 2018 Sep 25; 24():6774-6780. PubMed ID: 30252834
    [Abstract] [Full Text] [Related]

  • 13. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I, Algun E, Incecayir O, Ersoy K.
    Metab Syndr Relat Disord; 2011 Oct 25; 9(5):375-80. PubMed ID: 21657888
    [Abstract] [Full Text] [Related]

  • 14. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE.
    J Clin Endocrinol Metab; 2003 Oct 25; 88(10):4682-8. PubMed ID: 14557441
    [Abstract] [Full Text] [Related]

  • 15. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
    Cupisti S, Häberle L, Dittrich R, Oppelt PG, Reissmann C, Kronawitter D, Beckmann MW, Mueller A.
    Fertil Steril; 2010 Jul 25; 94(2):673-7. PubMed ID: 19394003
    [Abstract] [Full Text] [Related]

  • 16. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1995 Oct 25; 80(10):2966-73. PubMed ID: 7559882
    [Abstract] [Full Text] [Related]

  • 17. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan 25; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 18. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S, Vaikkakara S, Sachan A, Venkatanarasu A, Bachimanchi B, Bitla A, Settipalli S, Pathiputturu S, Sugali RN, Chiri S.
    Gynecol Endocrinol; 2018 Mar 25; 34(3):238-242. PubMed ID: 29068242
    [Abstract] [Full Text] [Related]

  • 19. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO, Yarali H, Oguz H, Bayraktar M.
    J Clin Endocrinol Metab; 2003 May 25; 88(5):2031-6. PubMed ID: 12727950
    [Abstract] [Full Text] [Related]

  • 20. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep 25; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.